Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
20071.9k citationsHiroshi Furukawa et al.profile →
Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry
Countries citing papers authored by Hiroshi Furukawa
Since
Specialization
Citations
This map shows the geographic impact of Hiroshi Furukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Furukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Furukawa more than expected).
Fields of papers citing papers by Hiroshi Furukawa
This network shows the impact of papers produced by Hiroshi Furukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Furukawa. The network helps show where Hiroshi Furukawa may publish in the future.
Co-authorship network of co-authors of Hiroshi Furukawa
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Furukawa.
A scholar is included among the top collaborators of Hiroshi Furukawa based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Hiroshi Furukawa. Hiroshi Furukawa is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Muta, Osamu, et al.. (2014). A Zero-Forcing Relay Power Allocation Scheme for TDBC-Based Bidirectional Relay Networks. 113(465). 157–162.1 indexed citations
7.
Hashima, Sherief, et al.. (2013). Performance analysis of uplink Fractional Frequency Reuse using worst case Signal to Interference Ratio. 839–844.5 indexed citations
8.
Elwekeil, Mohamed, Masoud Alghoniemy, Mostafa El‐Khamy, Hiroshi Furukawa, & Osamu Muta. (2012). Optimal channel assignment for IEEE 802.11 Multi-cell WLANs. European Signal Processing Conference. 694–698.8 indexed citations
9.
Nishimoto, Hiroshi, et al.. (2009). Picomesh -A Wireless Backhaul with Wireless Multihop Relay for Pico Cellular Systems. 108(445). 331–336.1 indexed citations
10.
Furukawa, Hiroshi, et al.. (2007). A Highly Efficient Packet Forwarding Scheme for Wireless Multihop Networks with String Topology. 90(12). 1225–1238.2 indexed citations
Furukawa, Hiroshi. (1994). A microcell overlaid umbrella cell system. Medical Entomology and Zoology. 3. 1455–1459.
16.
Furukawa, Hiroshi, Makoto Watanabe, Taku Shirakawa, et al.. (1989). The Efficacy and Mechanism of Kobe Stump Socks against the Stump Eczema. Kobe University Repository Kernel (Kobe University). 5. 23–31.
Furukawa, Hiroshi, et al.. (1983). Effect of sex hormones on carcinogenesis of experimental gastric cancer -A chronological study-. 80(7). 1410–1414.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.